Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

BCAT-IN-2

Inquiry
Cat. No.: OB0425LY-131
Synonyms: 1800024-45-6; 2-((4-Chloro-2,6-difluorobenzyl)amino)-7-oxo-5-propyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile; 2-[(4-Chloro-2,6-difluorophenyl)methylamino]-7-oxo-5-propyl-1H-pyrazolo[1,5-a]pyrimidine-3-carbonitrile
Size: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg; 500 mg
CAS No.: 1800024-45-6
Compound CID: 78319104
BCAT-IN-2

Specification

Description: BCAT-IN-2 is a novel biochemical inhibitor that specifically targets branch chain amino acid transaminases (BCAT). BCAT inhibition affects amino acid metabolism, which regulates energy homeostasis.
Formula Weight: 377.78
Applications: BCAT-IN-2 is mainly used in the study of metabolism-related diseases and has potential applications especially in therapeutic studies of diabetes and obesity.
Storage: Storage at -20°C.
Formula: C17H14ClF2N5O
Appearance: Solid
Purity: 99.07%, determined by HPLC.
Solubility: DMSO
Pathway: Metabolic enzyme/Protease
Target: Aminotransferases (Transaminases)

Library Information

Solubility: DMSO
Inquiry

Copyright © Protheragen. All rights reserves.